首页> 外文期刊>Recent Patents on Inflammation & Allergy Drug Discovery >New Methods of Prevention and Treatment of Allergic Diseases
【24h】

New Methods of Prevention and Treatment of Allergic Diseases

机译:预防和治疗过敏性疾病的新方法

获取原文
获取原文并翻译 | 示例
       

摘要

Over the past decades, the increasing number of patients with allergic conditions has posed a heavy burden on health care systems worldwide. This article will review recent treatments and patented methods for preventing allergies and related inflammatory and immunologic diseases. New drugs are commonly directed to known mechanisms, but there are many other pathways on which drugs can exert their action. New drug development is expected in the future as a consequence of discoveries in the pathophysiology and mechanisms of these diseases. Pharmaceuticals which would prevent the development of atopic diseases could allow us treating patients with genetic or environmental risk factors according to their conditions. Currently, a good and effective set of treatments is available for these diseases. However, the search for new treatment modalities to improve the currently available is especially important for those patients unresponsive to current therapy. In this review, we summarize anti-cytokines therapies, Toll-like receptor (TLR)-mediated treatments, anti-immunoglobulin molecules, new immunomodulatory treatments and new antihistamines. The use of probiotics remains a matter of discussion and debate, since available studies have had contradictory results. In the present article, we discuss current treatments for atopic diseases such as extrinsic asthma, atopic dermatitis and allergic rhinitis and relevant patents.
机译:在过去的几十年中,越来越多的变态反应患者给全球的医疗保健系统带来了沉重的负担。本文将回顾预防过敏和相关的炎症和免疫疾病的最新治疗方法和专利方法。新药通常针对已知的机制,但是还有许多其他途径可以使药物发挥作用。由于发现了这些疾病的病理生理学和机制,因此有望在未来开发出新药。预防特应性疾病发展的药物可以使我们根据病情治疗具有遗传或环境危险因素的患者。当前,针对这些疾病的有效和有效的治疗方法是可用的。然而,对于那些对当前治疗无反应的患者,寻找新的治疗方式以改善当前可用的方法尤为重要。在这篇综述中,我们总结了抗细胞因子疗法,Toll样受体(TLR)介导的疗法,抗免疫球蛋白分子,新的免疫调节疗法和新的抗组胺药。益生菌的使用仍然是讨论和辩论的问题,因为现有的研究已经产生了矛盾的结果。在本文中,我们讨论了特应性疾病(例如外在性哮喘,特应性皮炎和过敏性鼻炎)的当前治疗方法以及相关专利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号